ArticleOncogene2019
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance.
A C Hepburn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papercites it